Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will participate in the H.C. Wainwright 27^th Annual Global Investment Conference taking place September 8-10, 2025 in New York City.

Read more at globenewswire.com